TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials. November 7, 2008
TCL Archive Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO May 25, 2007
TCL Archive NCI-Frederick Leases Office Building To Move Some Programs Off Army Base. February 26, 2010
